Evidence map›Paper›PMID 35681555›Full record

ArticleCancers2022

Deep Learning Using CT Images to Grade Clear Cell Renal Cell Carcinoma: Development and Validation of a Prediction Model.

Lifeng Xu, Chun Yang, Feng Zhang, Xuan Cheng, Yi Wei, Shixiao Fan, Minghui Liu, Xiaopeng He, Jiali Deng, Tianshu Xie and 3 more

Abstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. State of the art review of AI in renal imaging.Abdominal radiology (New York) · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Deep learning algorithm for pathological grading of renal cell carcinoma based on multi-phase enhanced CT.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lifeng XuThe Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China.
Chun YangYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou 324000, China.ORCID 0000-0002-7714-5713
Feng ZhangThe Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China.
Xuan ChengYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou 324000, China.ORCID 0000-0002-4234-6179
Yi WeiWest China Hospital, Sichuan University, Chengdu 610000, China.
Shixiao FanYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou 324000, China.
Minghui LiuYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou 324000, China.ORCID 0000-0002-3171-0270
Xiaopeng HeWest China Hospital, Sichuan University, Chengdu 610000, China.
Jiali DengYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou 324000, China.
Tianshu XieYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou 324000, China.ORCID 0000-0001-7021-8855
Xiaomin WangYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou 324000, China.
Ming LiuYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou 324000, China.
Bin SongWest China Hospital, Sichuan University, Chengdu 610000, China.

Funding

Science and Technology Department of Zhengjiang Province LGF22G010009Science and Technology Program of Quzhou Grant 2021D007Science and Technology Program of Quzhou Grant 2021D008Science and Technology Program of Quzhou Grant 2021D015Science and Technology Program of Quzhou Grant 2021D018
6 · The paper itself

Abstract

This retrospective study aimed to develop and validate deep-learning-based models for grading clear cell renal cell carcinoma (ccRCC) patients. A cohort enrolling 706 patients (

Indexed as

class imbalanceclear cell renal cell carcinomadeep learninglabel noiseself-supervised learningtumor grading

Identifiers

PMID35681555
PMCPMC9179576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.